$0.00040
-0.12-99.66%
Last update: Nov 10, 10:31 AM
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc.
SYRSOTCEM
The average analyst price target for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. is $3, 749900.0% above the current price. Of 5 analysts, 1 rates it Buy and 4 Hold. Targets range from $1 to $5. The latest change came on Nov 13, 2024, when TD Cowen downgraded SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. from Buy to Hold.
Price Target Range — 3 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
